Annual Short Term Debt
$81.89 M
+$71.25 M+669.40%
December 1, 2023
Summary
- As of February 8, 2025, SVA annual short term debt is $81.89 million, with the most recent change of +$71.25 million (+669.40%) on December 1, 2023.
- During the last 3 years, SVA annual short term debt has risen by +$39.28 million (+92.18%).
- SVA annual short term debt is now at all-time high.
Performance
SVA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$181.80 M
+$99.91 M+121.99%
June 1, 2024
Summary
- As of February 8, 2025, SVA quarterly short term debt is $181.80 million, with the most recent change of +$99.91 million (+121.99%) on June 1, 2024.
- Over the past year, SVA quarterly short term debt has dropped by -$29.47 million (-13.95%).
- SVA quarterly short term debt is now -13.95% below its all-time high of $211.27 million, reached on June 30, 2023.
Performance
SVA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
SVA Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +669.4% | -13.9% |
| 3 y3 years | +92.2% | +298.9% |
| 5 y5 years | +2366.0% | +1290.2% |
SVA Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +669.4% | -13.9% | +2180.5% |
| 5 y | 5-year | at high | +669.4% | -13.9% | +2180.5% |
| alltime | all time | at high | >+9999.0% | -13.9% | >+9999.0% |
Sinovac Biotech Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $181.80 M(+122.0%) |
| Dec 2023 | $81.89 M(+669.4%) | $81.89 M(-61.2%) |
| Jun 2023 | - | $211.27 M(+1884.8%) |
| Dec 2022 | $10.64 M(-29.4%) | $10.64 M(+33.5%) |
| Jun 2022 | - | $7.97 M(-47.1%) |
| Dec 2021 | $15.07 M(-64.6%) | $15.07 M(-66.9%) |
| Jun 2021 | - | $45.58 M(+7.0%) |
| Dec 2020 | $42.61 M(+225.9%) | $42.61 M(+15.1%) |
| Sep 2020 | - | $37.03 M(+69.5%) |
| Jun 2020 | - | $21.84 M(+16.8%) |
| Mar 2020 | - | $18.70 M(+43.0%) |
| Dec 2019 | $13.08 M(+293.8%) | $13.08 M(+177.8%) |
| Sep 2019 | - | $4.71 M(-35.7%) |
| Jun 2019 | - | $7.32 M(+38.6%) |
| Mar 2019 | - | $5.28 M(+59.0%) |
| Dec 2018 | $3.32 M(-81.7%) | $3.32 M(-66.1%) |
| Jun 2018 | - | $9.81 M(-46.0%) |
| Dec 2017 | $18.15 M(-45.9%) | $18.15 M(-25.0%) |
| Jun 2017 | - | $24.20 M(-27.9%) |
| Dec 2016 | $33.58 M(+38.5%) | $33.58 M(+5.5%) |
| Sep 2016 | - | $31.84 M(+21.4%) |
| Jun 2016 | - | $26.23 M(-21.1%) |
| Mar 2016 | - | $33.23 M(+37.1%) |
| Dec 2015 | $24.25 M(-51.5%) | $24.25 M(-11.8%) |
| Sep 2015 | - | $27.48 M(-22.0%) |
| Jun 2015 | - | $35.23 M(+6.3%) |
| Mar 2015 | - | $33.14 M(-33.7%) |
| Dec 2014 | $49.97 M(+155.7%) | $49.97 M(+6.0%) |
| Sep 2014 | - | $47.13 M(+20.2%) |
| Jun 2014 | - | $39.22 M(+8.7%) |
| Mar 2014 | - | $36.08 M(+84.6%) |
| Dec 2013 | $19.54 M | $19.54 M(+54.9%) |
| Sep 2013 | - | $12.61 M(+103.0%) |
| Jun 2013 | - | $6.21 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $5.75 M(+72.8%) |
| Dec 2012 | $3.33 M(-29.4%) | $3.33 M(-30.3%) |
| Sep 2012 | - | $4.77 M(+1.1%) |
| Jun 2012 | - | $4.72 M(-0.4%) |
| Mar 2012 | - | $4.74 M(+0.6%) |
| Dec 2011 | $4.71 M(-54.8%) | $4.71 M(-49.7%) |
| Sep 2011 | - | $9.37 M(+1.0%) |
| Jun 2011 | - | $9.28 M(-11.9%) |
| Mar 2011 | - | $10.53 M(+0.9%) |
| Dec 2010 | $10.44 M(-41.0%) | $10.44 M(+249.5%) |
| Sep 2010 | - | $2.99 M(+1.6%) |
| Jun 2010 | - | $2.94 M(-83.4%) |
| Mar 2010 | - | $17.70 M(+0.0%) |
| Dec 2009 | $17.70 M(+120.6%) | $17.70 M(-19.3%) |
| Sep 2009 | - | $21.94 M(-9.0%) |
| Jun 2009 | - | $24.11 M(+200.0%) |
| Mar 2009 | - | $8.03 M(+0.1%) |
| Dec 2008 | $8.02 M(+17.4%) | $8.02 M(+120.0%) |
| Sep 2008 | - | $3.65 M(-49.9%) |
| Jun 2008 | - | $7.28 M(+2.2%) |
| Mar 2008 | - | $7.12 M(+4.2%) |
| Dec 2007 | $6.84 M(+156.9%) | $6.84 M(+2.8%) |
| Sep 2007 | - | $6.65 M(+238.0%) |
| Jun 2007 | - | $1.97 M(-26.1%) |
| Dec 2006 | $2.66 M(+10.0%) | $2.66 M(-16.9%) |
| Jun 2006 | - | $3.20 M(+32.4%) |
| Dec 2005 | $2.42 M(-7.2%) | $2.42 M(-7.2%) |
| Jun 2005 | - | $2.60 M(-0.0%) |
| Dec 2004 | $2.61 M(+246.3%) | $2.61 M(+85.6%) |
| Sep 2004 | - | $1.40 M(+845.2%) |
| Jun 2004 | - | $148.50 K(-80.3%) |
| Dec 2003 | $752.40 K(>+9900.0%) | $752.40 K |
| Apr 2002 | $2500.00(+25.0%) | - |
| Apr 2001 | $2000.00(0.0%) | - |
| Apr 2000 | $2000.00 | - |
FAQ
- What is Sinovac Biotech annual short term debt?
- What is the all time high annual short term debt for Sinovac Biotech?
- What is Sinovac Biotech annual short term debt year-on-year change?
- What is Sinovac Biotech quarterly short term debt?
- What is the all time high quarterly short term debt for Sinovac Biotech?
- What is Sinovac Biotech quarterly short term debt year-on-year change?
What is Sinovac Biotech annual short term debt?
The current annual short term debt of SVA is $81.89 M
What is the all time high annual short term debt for Sinovac Biotech?
Sinovac Biotech all-time high annual short term debt is $81.89 M
What is Sinovac Biotech annual short term debt year-on-year change?
Over the past year, SVA annual short term debt has changed by +$71.25 M (+669.40%)
What is Sinovac Biotech quarterly short term debt?
The current quarterly short term debt of SVA is $181.80 M
What is the all time high quarterly short term debt for Sinovac Biotech?
Sinovac Biotech all-time high quarterly short term debt is $211.27 M
What is Sinovac Biotech quarterly short term debt year-on-year change?
Over the past year, SVA quarterly short term debt has changed by -$29.47 M (-13.95%)